BackJW Pharmaceutical Overview

JW Pharmaceutical Current Cash

Track JW Pharmaceutical's current cash ($44B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$44.15B
↑ 299.07% YoYΔ $33.08B vs prior year quarter

Peer trimmed avg / median

Loading

JW Pharmaceutical Current Cash History

Loading

JW Pharmaceutical vs. peers: Current Cash Comparison

Loading

JW Pharmaceutical Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

JW Pharmaceutical (001065.KS) FAQ

The latest current cash for 001065.KS is $44B as of June 2026. That compares with $11B in the prior-year period — up 299.1% year over year. Investors often review this figure alongside JW Pharmaceutical's historical trend and sector peers before judging valuation or financial health.

Over the past year, 001065.KS's current cash moved from $11B to $44B — a 299.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in JW Pharmaceutical's operating scale or balance-sheet position.

A current cash figure of $44B for 001065.KS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 001065.KS's current cash ($44B), review year-over-year change from $11B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.